/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

L

Ling Yan Wong

BC Cancer Agency(CA)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

4

Papers

127

Citations

2

h-index

2

i10-index

Ling Yan Wong is an academic researcher from BC Cancer Agency. The author has contributed to research in topics: HER2/EGFR in Cancer Research & PI3K/AKT/mTOR signaling in cancer & Lung Cancer Treatments and Mutations. The author has an h-index of 2, co-authored 4 publications.

Research Topics

HER2/EGFR in Cancer Research PI3K/AKT/mTOR signaling in cancer Lung Cancer Treatments and Mutations Autophagy in Disease and Therapy Monoclonal and Polyclonal Antibodies Research

Papers by this author

works

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

2011 · BMC Cancer · 28 citations

https://doi.org/10.1186/1471-2407-11-420

Wieslawa H. Dragowska Sherry A. Weppler Mohammed A. Qadir Ling Yan Wong

Research topics

topics

HER2/EGFR in Cancer Research

PI3K/AKT/mTOR signaling in cancer

Lung Cancer Treatments and Mutations

Autophagy in Disease and Therapy

Monoclonal and Polyclonal Antibodies Research

Chat about Author

Papers

Chat

Click to start Chat